Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Feb 14, 2022 8:30 AM - Feb 16, 2022 2:15 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

Session 3: Progress Towards Structured Submission Documents: ICH M11 and the Clinical Electronic Structured Harmonized Protocol (CeSHarP)

Session Chair(s)

Stacy  Tegan

Stacy Tegan

Program Director

Transcelerate Biopharma, Inc., United States

All clinical content and data trace their origins to the clinical study protocol. Currently there is no internationally harmonized format or content standards for the protocol document. It’s often submitted as essentially electronic paper (PDF) with limited ability to leverage the wealth of information with. The lack of a structured, electronic, harmonized protocol contributes to inefficiencies and difficulties in reviewing and assessing clinical protocols across stakeholders. This session will provide an depth overview of the ICH M11 Clinical electronic Structured Harmonized Protocol (CeSHarP) including the latest developments on an (1) international guideline, (2) protocol template, and (3) internationally accepted technical specification (implementation guide) to promote development of structured and unstructured protocol content, application of international data standards, and interoperable/compatible electronic exchange.

Learning Objective :
  • Explain the benefits and opportunities that will be created for various stakeholders with electronic exchange of a an internationally harmonized, structure protocol
  • Describe the planned deliverables and the latest developments on each including the ICH guideline, protocol template, and technical specification
  • Consider impacts of M11 on the breadth of clinical studies in scope and its aim to accommodate regional/local regulations

Speaker(s)

Ron  Fitzmartin, PhD, MBA

Speaker

Ron Fitzmartin, PhD, MBA

FDA, United States

Senior Advisor, Office of Regulatory Operations, CBER

Mitzi  Allred, PhD

Speaker

Mitzi Allred, PhD

Merck & Co., Inc, United States

Director, Clinical Operations

Mary Lynn  Mercado, PhD

Speaker

Mary Lynn Mercado, PhD

Novartis Pharmaceuticals Corporation, United States

Senior Group Head Regulatory Writing

Vaishali  Popat, MD, MPH

Speaker

Vaishali Popat, MD, MPH

FDA, United States

Branch Chief, Office of Clinical Evaluation,Office of Therapeutic Products, CBER

Panagiotis  Telonis

Speaker

Panagiotis Telonis

European Medicines Agency, Netherlands

Scientific Administrator, Data Standardisation and Analytics Department

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.